Evaluation of a General Practice Based Hepatitis C Virus Screening Intervention

被引:0
作者
Anderson, E. M. [1 ]
Mandeville, R. P. [2 ]
Hutchinson, S. J. [3 ,4 ]
Cameron, S. O. [5 ]
Mills, P. R. [6 ]
Fox, R. [7 ]
Ahmed, S. [1 ]
Taylor, A. [8 ,9 ]
Spence, E. [6 ]
Goldberg, D. J. [4 ]
机构
[1] NHS Greater Glasgow & Clyde, Publ Hlth Protect Unit, Glasgow, Lanark, Scotland
[2] Possilpk Hlth Ctr, Glasgow, Lanark, Scotland
[3] Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow, Lanark, Scotland
[4] Hlth Protect Scotland, Glasgow, Lanark, Scotland
[5] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland
[6] Gartnavel Royal Hosp, Gastroenterol Unit, Glasgow, Lanark, Scotland
[7] Gartnavel Royal Hosp, Infect Dis Unit, Brownlee Ctr, Glasgow, Lanark, Scotland
[8] Univ W Scotland, Inst Appl Social & Hlth Res, Paisley, Renfrew, Scotland
[9] Univ W Scotland, Sch Social Sci, Paisley, Renfrew, Scotland
关键词
STRATEGIES; INFECTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In 2003 an estimated 37,500 of Scotland's population was chronically infected with HCV; 44% were undiagnosed former injecting drug users (IDU) - a priority group for antiviral therapy. Aim To evaluate a hepatitis C virus (HCV) screening intervention. Design Outcome measures among two similar General Practice populations in an area of high HCV and drug use prevalence, one of which was exposed to an HCV screening intervention, were compared, Methods Thirty to fifty four year old attendees of the intervention practice were opportunistically offered testing and counselling, where clinically appropriate, (November 2003- April 2004). Outcomes: HCV test uptake, case detection, referral and treatment administration rates. Results Of 584 eligible attendees, 421 (72%) were offered and 117 (28%) accepted testing in the intervention practice; no testing was undertaken in the comparison practice. Prevalences of HCV antibody were 13% (15/117), 75% (3/4) and 91% (10/11) among all tested persons, current IDUs and former IDUs respectively. For 4/15 (27%) evidence of binge drinking following the receipt of their positive result, was available. Of the 11 referred to specialist care because they were HCV RNA positive, nine attended at least one appointment. Two received treatment: one had achieved a sustained viral response as of February 2008. Conclusion While non targeted HCV screening in the general practice setting can detect infected former IDU, the low diagnostic yield among non IDUs limited the effectiveness of the intervention. A more targeted approach for identifying former IDUs is recommended. Additionally, the low uptake of treatment among chronically infected persons four years after diagnosis demonstrates the difficulties in clinically managing such individuals. Strategies, including support for those with a history of problem alcohol use, to improve treatment uptake are required.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 50 条
[41]   Optimization of hepatitis C virus screening strategies by birth cohort in Italy [J].
Kondili, Loreta A. ;
Gamkrelidze, Ivane ;
Blach, Sarah ;
Marcellusi, Andrea ;
Galli, Massimo ;
Petta, Salvatore ;
Puoti, Massimo ;
Vella, Stefano ;
Razavi, Homie ;
Craxi, Antonio ;
Mennini, Francesco S. .
LIVER INTERNATIONAL, 2020, 40 (07) :1545-1555
[42]   Economic model of a birth cohort screening program for hepatitis C virus [J].
McGarry, Lisa J. ;
Pawar, Vivek S. ;
Panchmatia, Hemangi R. ;
Rubin, Jaime L. ;
Davis, Gary L. ;
Younossi, Zobair M. ;
Capretta, James C. ;
O'Grady, Michael J. ;
Weinstein, Milton C. .
HEPATOLOGY, 2012, 55 (05) :1344-1355
[43]   Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center [J].
Torres, Harrys A. ;
Mustafayev, Khalis ;
Juneau, Ruston P. ;
Hwang, Jessica P. ;
Wang, Lan Sun ;
Angelidakis, Georgios ;
Hawk, Ernest ;
Granwehr, Bruno P. ;
Guevara, Eduardo Yepez ;
Ying, Anita K. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D)
[44]   Molecular evaluation of hepatitis G virus and hepatitis C virus in patients with chronic renal failure in Iran [J].
Mohsenzadeh, Mehdi ;
Jafari, Mohamad ;
Afkari, Rouhi ;
Yaghobi, Ramin ;
Pirouzi, Aliyar .
AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (33) :6257-6261
[45]   Targets for Hepatitis C virus test uptake and case-finding among injecting drug users: In prisons and general practice [J].
Bird, Sheila M. ;
Robertson, Roy ;
Beresford, Hannah ;
Hutchinson, Sharon J. .
ADDICTION RESEARCH & THEORY, 2010, 18 (04) :421-432
[46]   Prescribing direct-acting antivirals to treat hepatitis C virus in a general practice setting in Australia: 'so why not do it'? [J].
Heard, Emma ;
Massi, Luciana ;
Smirnov, Andrew ;
Selvey, Linda A. .
INTERNAL MEDICINE JOURNAL, 2020, 50 (09) :1053-1058
[47]   Evaluation and Treatment of Hepatitis C in Patients with Human Immunodeficiency Virus [J].
Bakaj, Gentiana ;
Valasiuk, Tatsiana ;
Prabhukhot, Rupali ;
Siraj, Dawd .
SOUTHERN MEDICAL JOURNAL, 2012, 105 (10) :500-503
[48]   Diagnosis and evaluation of hepatitis C virus among haemodialysis patients [J].
Bahadi, A. ;
Maoujoud, O. ;
Zejjari, Y. ;
Alayoud, A. ;
Hassani, K. ;
Elkabbaj, D. ;
Benyahia, M. .
EASTERN MEDITERRANEAN HEALTH JOURNAL, 2013, 19 (02) :192-199
[49]   Development and clinical evaluation of a microarray for hepatitis C virus genotyping [J].
Park, Jae-Chan ;
Kim, Jong-Man ;
Kwon, Oh-Joong ;
Lee, Kyoung-Ryul ;
Cha, Young-Guy ;
Oh, Heung-Bum .
JOURNAL OF VIROLOGICAL METHODS, 2010, 163 (02) :269-275
[50]   Healthcare value of implementing hepatitis C screening in the adult general population in Spain [J].
Buti, Maria ;
Dominguez-Hernandez, Raquel ;
Angel Casado, Miguel ;
Sabater, Eliazar ;
Esteban, Rafael .
PLOS ONE, 2018, 13 (11)